5 reports

Alzumab is an anti-CD## monoclonal antibody.

  • Autoimmune Disease
  • Monoclonal Antibody
  • Therapy
  • AbbVie Inc.
  • Sandoz Inc.

Monoclonal antibodies (mAbs) are the newest class of drugs, predominately used in the treatment of psoriasis.

  • Dermatological Condition
  • Dermatology
  • Monoclonal Antibody
  • Therapy
  • Sandoz Inc.

TWO MONOCLONAL ANTIBODY (MAB) THERAPIES ARE UNDERGOING CLINICAL TRIALS, ONE OF WHICH IS IN PHASE III.

  • Biosimilar
  • Medical Biotechnology
  • Monoclonal Antibody
  • Therapy
  • Sandoz Inc.

In particular, the diversification in pharmaceutical therapeutics has led to a transformation in both the clinical and commercial landscape with the advent of monoclonal antibodies (mAb).

  • Clinical Trial
  • Monoclonal Antibody
  • Pharmaceutical
  • Therapy
  • Sandoz Inc.

Xilonix (MABp##) is a first-in-class human immunoglobulin G## (IgG##) monoclonal antibody being developed by XBiotech to treat the debilitating symptoms of colorectal cancer, including cachexia.

  • Cancer
  • Chemotherapy
  • Monoclonal Antibody
  • Therapy
  • Sandoz Inc.